Publicaciones en las que colabora con JOSÉ LUÑO FERNÁNDEZ (179)

2021

  1. Obesity related risk for chronic kidney disease progression and cardiovascular disease after propensity score matching

    Hipertension y Riesgo Vascular, Vol. 38, Núm. 2, pp. 63-71

  2. Riesgo relacionado con la obesidad para la progresión de insuficiencia renal crónica y enfermedad cardiovascular tras emparejamiento por puntaje de propensión

    Hipertensión y riesgo vascular, Vol. 38, Núm. 2, pp. 63-71

2020

  1. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain

    Kidney International

  2. Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists

    Nefrologia, Vol. 40, Núm. 1, pp. 66-74

  3. Definiciones de hipotensión intradiálisis con poder predictivo de mortalidad en una cohorte de hemodiálisis

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 40, Núm. 4, pp. 403-413

  4. Exercise training during hemodialysis sessions: Physical and biochemical benefits

    Therapeutic Apheresis and Dialysis, Vol. 24, Núm. 6, pp. 648-654

  5. Intradialytic hypotension definitions with mortality prediction capacity in a cohort of haemodialysis patients

    Nefrologia, Vol. 40, Núm. 4, pp. 402-412

  6. Progresión de la enfermedad renal crónica en pacientes con hipertensión resistente sometidos a 2 estrategias terapéuticas: intensificación con diuréticos de asa vs. antagonistas de la aldosterona

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 40, Núm. 1, pp. 65-73

2019

  1. An old disease, a new diagnosis; A 49 year-old man with nephrotic syndrome

    Journal of Nephropathology, Vol. 8, Núm. 3

  2. Body composition influences the elimination of protein-bound uraemic toxins in online haemodiafiltration

    Nefrologia

  3. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 2, pp. 128-139

  4. Evaluation of the efficacy of a very high permeability dialyser and comparison with another high-flux dialyser in online haemodiafiltration

    Clinical Kidney Journal

  5. High convective volumes are associated with improvement in metabolic profile in diabetic patients on online haemodiafiltration

    Nefrologia, Vol. 39, Núm. 2, pp. 168-176

  6. Middle molecule elimination in expanded haemodialysis: Only convective transport?

    Clinical Kidney Journal, Vol. 12, Núm. 3, pp. 447-455

  7. Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals

    Clinical Kidney Journal, Vol. 12, Núm. 3, pp. 362-364

  8. Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1

    Clinical Kidney Journal, Vol. 12, Núm. 3, pp. 420-426

  9. Pentoxifylline, progression of chronic kidney disease (CKD) and cardiovascular mortality: long-term follow-up of a randomized clinical trial

    Journal of Nephrology, Vol. 32, Núm. 4, pp. 581-587

  10. Returning to haemodialysis after kidney allograft failure: A survival study with propensity score matching

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 4, pp. 667-672

  11. The new marker YKL-40, a molecule related to inflammation, is associated with cardiovascular events in stable haemodialysis patients

    Clinical Kidney Journal, Vol. 13, Núm. 2, pp. 172-178

2018

  1. Any grade of relative overhydration is associated with long-term mortality in patients with Stages 4 and 5 non-dialysis chronic kidney disease

    Clinical Kidney Journal, Vol. 11, Núm. 3, pp. 372-376